PR Newswire · Press release
Quest Diagnostics Declares Quarterly Cash Dividend
AI summary
Summary by Wenlo · not part of the original release
Quest Diagnostics announced a quarterly cash dividend of $0.86 per share on November 10, 2026. The dividend is payable on January 27, 2027, to shareholders of record on January 12, 2027.
AI summaries can miss details: read the full release below. Not investment advice.
Original release from PR Newswire
As distributed by PR Newswire, unedited.
SECAUCUS, N.J., Nov. 10, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.86 per share, payable on January 27, 2027, to shareholders of record of Quest Diagnostics common stock on January 12, 2027.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302935557.html
SOURCE Quest Diagnostics
